Buckhalter Matthew 4

What Happened

• Matthew Buckhalter, Chief Financial Officer of Aveanna Healthcare (AVAH), was issued/received a total of 128,293 shares on February 14, 2026 via awards and vesting of restricted stock units (RSUs). The filing shows three award items: 15,213 shares, 46,875 shares, and 66,205 shares, each acquired at $0.00 per share (stock-settled awards/vests), so the reported acquisition price is $0. These transactions are compensation-related awards/vests rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-02-14; Form 4 filed: 2026-02-17 (three days later).
• Shares acquired: 15,213; 46,875; and 66,205 — total 128,293 shares. Reported acquisition price: $0.00 per share.
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1: Shares earned on vesting of performance-based RSUs from the Company’s 2022 long-term incentive awards.
  • F2: Shares earned on vesting of performance-based RSUs from the Company’s 2023 long-term incentive awards.
  • F3: Grant of stock-settled restricted stock units subject to three-year cliff vesting (no vest until end of three-year period).
• Filing timing: Filed Feb 17, 2026. SEC Form 4s must generally be filed within two business days; because the transaction date fell on a weekend (Feb 14) and Feb 16 was a federal holiday, the Feb 17 filing appears consistent with typical timing rules.

Context

• These are compensation-related awards/vests (A = Award/Grant). An acquisition price of $0 is standard for RSUs converting into shares — it does not represent cash purchase. Such transactions reflect executive compensation and vesting schedules rather than an explicit buy or sell signal by the insider.
• The F3 grant is time-based with a three-year cliff, meaning those units won’t vest until the cliff period ends. The F1/F2 items reflect performance-based awards that vested.